Keywords: ACT, adoptive cell therapy; AICD, activation-induced cell death; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CAR, chimeric antigen receptor; CIK, cytokine-induced killer; CML, chronic myeloid leukemia; CMV, Cytomegalovirus; CTL, cytoto